Non-classical topical treatment for glaucoma using n-substituted

Details Non-classical topical treatment for glaucoma using n-substituted Non-classical topical treatment for glaucoma using n-substituted

1983-07-11

1984-11-20

Robinson, Douglas W.

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Recombinant or stably-transformed bacterium encoding one or...

A61K 3118

Patent

active

044838727

ABSTRACT:
A topical composition for eye treatment of glaucoma, comprising a small but pharmaceutically effective amount of a non-classical carbonic anhydrase inhibitor. The most preferred compound is methyl acetazolamide. The invention also relates to a method of topically treating glaucoma with eye drops of a non-classical carbonic anhydrase inhibitor to reduce intraocular pressure.

REFERENCES:
patent: 4305927 (1981-12-01), Theeuwes et al.
Gelatt et al.-Am. J. Vet. Res., 40 (3), 334-345, (1979).
AMA Drug Eval., 2nd ed., (1973)-pp. 676, 678, 679 and 684-685.

Affiliated with

Also associated with

Rating

Non-classical topical treatment for glaucoma using n-substituted does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Non-classical topical treatment for glaucoma using n-substituted, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Non-classical topical treatment for glaucoma using n-substituted will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2189117